K

Kura Oncology

D
KURA
USD
-1.275
(-7.1811%)
Market Closed
0.000000
حجم التداول
-2.46
الربح لكل سهم
-
العائد الربحي
-7.390135
P/E
1,262,936,494.08
حجم السوق
اليوم
-7.1811%
1 اسبوع
-7.155%
1 شهر
-8.698%
6 اشهر
-21.186%
12 اشهر
78.936%
بداية السنة
14.524%
كل الوقت
0%
avatar
sara abdelazim
عدد النقاط
112
عدد التوصيات
2

Title:
Kura Oncology

Sector:
Healthcare
Industry:
Biotechnology
Kura Oncology Inc is a clinical-stage biopharmaceutical company, that engages in discovering and developing therapeutics for the treatment of solid tumors and blood cancers. It focuses on the development of small-molecule product candidates that target cell signaling pathways to drive the progression of various cancers. The company has a product candidate, Tipifarnib, which is a farnesyl transferase inhibitor, in both solid tumors and blood cancers. Geographically operationof the group is carried through the United States.
هل تحتاج مساعدة او لديك استفسار؟